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Abstract
Background: The most common malignancy to cause gastric outlet obstruction is primary gastric adenocarcinoma
and it is followed by carcinoma of the pancreas and gallbladder. Herein, we report a case of gastric outlet obstruction
secondary to metastatic lobular breast carcinoma.
Case presentation: Fifty-seven year old Caucasian female with recently diagnosed metastatic lobular breast carcinoma
to skin was referred to gastroenterology for evaluation of dyspepsia and dysphagia. She has past medical history
significant for acid reflux and Clostridium difficile colitis. Computed tomography of her abdomen showed diffused
bowel wall thickening without evidence of bowel obstruction. Due to persistent abdominal pain, an upper endoscopy
was performed. The upper endoscopy showed gastritis and gastric stenosis in the gastric antrum. These lesions were
biopsied and dilated with a balloon dilator. The biopsy of the gastric antrum later showed a metastatic carcinoma of
breast origin with typical tumor morphology and immune-phenotype.
Conclusions: Differentiating metastatic breast carcinoma from primary gastric adenocarcinoma cannot be done using
histological examination alone. Immunohistochemistry is needed to differentiate the two based on staining for estrogen
and progesterone receptors. The presence of gross cystic disease fluid protein 15 is also suggestive of metastatic breast
carcinoma. The stomach has a significant capacity to distend (up to 2–4 L of food) and malignant gastric outlet
obstruction is often undetected clinically until a high-grade obstruction develops. Our case demonstrates valuable
teaching point in terms of broadening our differentials for gastric outlet obstruction. When patients present with gastric
outlet obstruction, both non-malignant and malignant causes of gastric outlet obstruction should be considered. Once
adenocarcinoma has been determined to be the cause of gastric outlet obstruction, further immunohistochemistry is
needed to differentiate breast carcinoma from other carcinomas.
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Background
Gastric outlet obstruction (GOO) can be a complication
of malignancy, gastric polyps, peptic ulcer disease, or
gallstone obstruction. Since the advent of histamine-2
blocker in the late 1970s, the incidence of GOO from
duodenal ulcer has declined dramatically and the malig-
nancy accounts for as many as 61 % of GOO [1]. The
most common malignancy to cause GOO is primary
gastric adenocarcinoma and it is followed by carcinoma
of the pancreas and gallbladder [1, 2]. Herein, we report
a case of gastric outlet obstruction secondary to meta-
static lobular breast carcinoma. There are several case
reports regarding GOO secondary to metastatic breast
cancer and it is an extremely rare cause of obstructions
per literature review from 1995 to date.
Case presentation
Fifty-seven year old female with recently diagnosed meta-
static lobular breast carcinoma to skin was referred to
gastroenterology team for evaluation of dyspepsia and
dysphagia. She has past medical history significant for
gastroesophageal reflux disease (GERD) and Clostridium
difficile colitis. She was previously evaluated in the emer-
gency department for abdominal pain. CT scan of her
abdomen showed diffused bowel wall thickening without
evidence of bowel obstruction (Fig 1). Her CBC was unre-
markable without leukocytosis. LFT’s were not elevated
and lipase level was normal at 30 U/L. Due to absence of
acute medical issue, she was discharged to home from the
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emergency department. The patient was seen by oncology
team as outpatient soon after her recent ED visit for fur-
ther evaluation of the recently diagnosed breast cancer by
skin biopsy under the right breast. The biopsy showed a
metastatic lobular carcinoma and the estrogen receptor
on these cells was strongly positive in 100 % of the cells.
The progesterone receptor was negative and the Her-2/neu
expression was negative by the FISH assay. She contin-
ued to complain of abdominal pain and difficulty with
swallowing to her oncologist. An esophagogastroduode-
noscopy (EGD) was performed subsequently to evaluate
her dyspepsia and dysphagia. The EGD showed gastritis
and gastric stenosis in the gastric antrum (Fig 2). These
lesions were biopsied and dilated with a balloon dilator.
The biopsy of the gastric antrum later showed a tumor
with morphology of relatively uniform cells growing in
single files in the lamina propria (Fig 3). The immune-
reactivity was positive for cytokeratin 7, gross cystic
disease fluid protein (GCDFP) 15, estrogen receptor (ER)
and GATA-3 (Figs 4, 5 and 6). The immunostaining pro-
file and tumor morphology were consistent with a meta-
static carcinoma of breast origin.
Fig. 1 EGD. Esophagogastroduodenoscopy images showing gastric outlet obstruction at the gastric antrum
Fig. 2 CT scan. CT scan of abdomen without IV or PO contrast showing thickening of the gastric antrum
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Conclusions
Differentiating metastatic breast carcinoma from primary
gastric adenocarcinoma cannot be safely done using histo-
logical examination alone. However, less pleomorphic
tumor morphology and single file pattern are commonly
seen in lobular carcinoma of breast. Immunohistochemis-
try is required to differentiate the two based on staining
for a panel of immnohistochemical markers including
GATA-3, CDX-2, GCDFP-15, and estrogen receptors.
While GATA-3 is currently considered as a better marker
for breast cancer, diffuse strong ER positivity and presence
of GCDFP 15 are also suggestive of metastatic breast car-
cinoma [3]. GATA3 is a sensitive and specific marker for
diagnosis of breast carcinomas [4]. The stomach has a
significant capacity to distend (up to 2–4 L of food) and
malignant GOO is often undetected clinically until a high-
grade obstruction develops [5]. Gastrointestinal (GI)
metastasis from breast cancer is extremely rare and
accounts for less than one percentage of metastatic breast
cancers [6]. The most common sites of GI track metasta-
sis from breast cancer are colon and rectum [7]. Metasta-
sis to stomach only accounts for a small fraction of GI
track metastasis from breast cancer [8]. Gastrointestinal
metastasis from breast is associated with poor prognosis
[9]. Our case demonstrates valuable teaching point in
terms of broadening our differentials for GOO. When
patients present with GOO, both non-malignant and
malignant causes of GOO should be considered. Once
adenocarcinoma has been determined to be the cause of
GOO, further immunohistochemistry is needed to differ-
entiate breast carcinoma from other carcinomas.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor of this journal.
Fig. 5 Cytokeratin 7. The tumor cells in the lamina propria are
positive for cytokeratin 7 immunostaining
Fig. 6 GATA-3. The tumor cells show positive nuclear stain for
GATA-3 (a marker for breast cancer)
Fig. 3 Lower power field. Lower power shows relatively bland
looking tumor cells expanding the lamina propria of the mucosa
Fig. 4 Estrogen receptor. The tumor cells are positive for nuclear
staining of estrogen receptor
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